The use of fulvestrant before chemotherapy improves survival in hormone-positive breast cancer: a real-life study

BACKGROUND/AIM: We aimed to evaluate the efficacy of fulvestrant and its affecting clinical factors, including the optimal sequencing of fulvestrant and chemotherapy in a real-life cohort. METHODS: The data of 256 metastatic hormone-positive breast cancer patients treated with fulvestrant were evalu...

Descripción completa

Detalles Bibliográficos
Autores principales: GÜVEN, Deniz Can, YILDIRIM, Hasan Çağrı, ERUL, Enes, ŞAHİN, Taha Koray, ÇAKIR, İbrahim Yahya, AKTEPE, Oktay Halit, KERTMEN, Neyran, DİZDAR, Ömer, AKSOY, Sercan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Scientific and Technological Research Council of Turkey (TUBITAK) 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10395701/
https://www.ncbi.nlm.nih.gov/pubmed/36422490
http://dx.doi.org/10.55730/1300-0144.5495

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10395701/
https://www.ncbi.nlm.nih.gov/pubmed/36422490
http://dx.doi.org/10.55730/1300-0144.5495

Ejemplares similares